Cargando…
Excitatory Neurons Derived from Human-Induced Pluripotent Stem Cells Show Transcriptomic Differences in Alzheimer’s Patients from Controls
The recent advances in creating pluripotent stem cells from somatic cells and differentiating them into a variety of cell types is allowing us to study them without the caveats associated with disease-related changes. We generated induced Pluripotent Stem Cells (iPSCs) from eight Alzheimer’s disease...
Autores principales: | Sagar, Ram, Azoidis, Ioannis, Zivko, Cristina, Xydia, Ariadni, Oh, Esther S., Rosenberg, Paul B., Lyketsos, Constantine G., Mahairaki, Vasiliki, Avramopoulos, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10417412/ https://www.ncbi.nlm.nih.gov/pubmed/37566069 http://dx.doi.org/10.3390/cells12151990 |
Ejemplares similares
-
Improving the Utility of Polygenic Risk Scores as a Biomarker for Alzheimer’s Disease
por: Vlachakis, Dimitrios, et al.
Publicado: (2021) -
Lipid-based nanoparticles and RNA as innovative neuro-therapeutics
por: Tsakiri, Maria, et al.
Publicado: (2022) -
Principles and management of neuropsychiatric symptoms in Alzheimer’s dementia
por: Nowrangi, Milap A, et al.
Publicado: (2015) -
Alzheimer’s disease and the fornix
por: Oishi, Kenichi, et al.
Publicado: (2014) -
Neuronal-Derived EV Biomarkers Track Cognitive Decline in Alzheimer’s Disease
por: Eren, Erden, et al.
Publicado: (2022)